Dataset Information


Secretome-based identification of ULBP2 as a novel serum marker for pancreatic cancer detection.

ABSTRACT: BACKGROUND: To discover novel markers for improving the efficacy of pancreatic cancer (PC) diagnosis, the secretome of two PC cell lines (BxPC-3 and MIA PaCa-2) was profiled. UL16 binding protein 2 (ULBP2), one of the proteins identified in the PC cell secretome, was selected for evaluation as a biomarker for PC detection because its mRNA level was also found to be significantly elevated in PC tissues. METHODS: ULBP2 expression in PC tissues from 67 patients was studied by immunohistochemistry. ULBP2 serum levels in 154 PC patients and 142 healthy controls were measured by bead-based immunoassay, and the efficacy of serum ULBP2 for PC detection was compared with the widely used serological PC marker carbohydrate antigen 19-9 (CA 19-9). RESULTS: Immunohistochemical analyses revealed an elevated expression of ULPB2 in PC tissues compared with adjacent non-cancerous tissues. Meanwhile, the serum levels of ULBP2 among all PC patients (n?=?154) and in early-stage cancer patients were significantly higher than those in healthy controls (p<0.0001). The combination of ULBP2 and CA 19-9 outperformed each marker alone in distinguishing PC patients from healthy individuals. Importantly, an analysis of the area under receiver operating characteristic curves showed that ULBP2 was superior to CA 19-9 in discriminating patients with early-stage PC from healthy controls. CONCLUSIONS: Collectively, our results indicate that ULBP2 may represent a novel and useful serum biomarker for pancreatic cancer primary screening.

PROVIDER: S-EPMC3098863 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC6219528 | BioStudies
| S-EPMC4868723 | BioStudies
| S-EPMC3408036 | BioStudies
| S-EPMC5865497 | BioStudies
2016-10-30 | GSE85589 | GEO
| S-EPMC7352809 | BioStudies
| S-EPMC7659308 | BioStudies
| S-EPMC5342537 | BioStudies
| S-EPMC7591991 | BioStudies
| S-EPMC7843497 | BioStudies